Making behavioral health measurable for health plans: NeuroFlow company briefing and Q&A with co-founder & CEO Christopher Molaro

Christopher Molaro, Co-Founder and CEO at NeuroFlow, sat down with HTN’s Martin Cech on October 6, 2026 to discuss the new DSF-E HEDIS measure and what it means for Medicare Advantage star ratings, pay-for-performance models for Medicaid behavioral health networks, and how to measure outcomes for fast-acting treatments like TMS and esketamine.